Markets · 1 sources covering this

Stock to buy for long-term: Angel One sees 39% upside in this Gujarat-based pharma stock. Should you buy?

Stock to buy for long-term: Shares of Lincoln Pharmaceuticals Ltd have remained under profit-booking pressure after hitting a 52-week high at the end of May 2026

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 0 C · 1 R

How 1 sources are covering this

MintLean R·3h ago
Stock to buy for long-term: Angel One sees 39% upside in this Gujarat-based pharma stock. Should you buy?
Stock to buy for long-term: Shares of Lincoln Pharmaceuticals Ltd have remained under profit-booking pressure after hitting a 52-week high at the end of May 2026
Read at Mint →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/5252c771452c9c105184f1a39fceeef9e164b8f4"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Stock to buy for long-term: Angel One sees 39% upside in this Gujarat-based pharma stock. Should you buy?"></iframe>

Stock to buy for long-term: Angel One sees 39% upside in this Gujarat-based pharma stock. Should you buy?

How 1 sources are covering this

Stock to buy for long-term: Angel One sees 39% upside in this Gujarat-based pharma stock. Should you buy?

More from Markets

Binance Blockchain Week 2026: Here is what to expect at the two-day Bangkok event

Indiabulls says the EOW status report does not mention any wrongdoing in a major loan case

Mint Explainer | Why Sebi wants to revamp its settlement framework

Shiprocket shares make strong debut: Stock lists at 35% premium over IPO price at Rs 131

Reader

Trust & legal

Across the network